Penicillin Allergy Awareness - Rethinking and Reevaluating Penicillin Allergy

Prepare for National Penicillin Allergy Awareness Day by Utilizing AAAAI Resources and Sharing Educational Materials

MILWAUKEE, Sept. 22, 2026 /PRNewswire/ -- September 28 is National Penicillin Allergy Day. More than 90% of patients with a documented penicillin allergy in their electronic medical records can safely take penicillin after evaluation. Because penicillin remains the most effective treatment for many infections, patients with an inaccurate penicillin allergy label are not getting the care they need. Removing an unnecessary penicillin allergy label, known as "de-labeling," improves patient outcomes, reduces healthcare costs and advances the fight against antimicrobial resistance.

When addressing penicillin allergy, it's imperative to question the diagnosis, evaluate the allergy and advance patient care. As the leading member organization of allergist/immunologists, the AAAAI is committed to serving as a trusted source of information regarding penicillin allergy and its effects on public health.

Learn more about penicillin allergy de-labeling with these valuable resources and educational materials:

• The AAAAI Penicillin Allergy Center features educational and outreach materials for medical professionals including podcasts, informative videos, social media graphics, practice resources and more.

• Penicillin allergy testing is safe for children and adults. Explore the AAAAI's Penicillin Allergy Position Statement for more information.

• The Penicillin Allergy Verification and Evaluation (PAVE) Act (H.R. 5736), developed in collaboration with the AAAAI and with bipartisan support from members of Congress, would require penicillin allergy verification and evaluation to be included in Medicare's Initial Preventative Physical Exam (IPPE) and Annual Wellness Visit (AWV). Reach out to members of congress through our advocacy platform, AAAAI Advocate, to express support for the PAVE Act.

• Explore additional AAAAI advocacy initiatives in the fight against antibiotic and antimicrobial resistance.

• AAAAI experts are available for media requests and interviews to discuss penicillin allergy and the importance of de-labeling. Email [email protected] to request an interview with an AAAAI expert.

• Visit aaaai.org to learn more about penicillin allergy and join the fight for antibiotic stewardship.

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists and other professionals with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI is the go-to resource for patients living with allergies, asthma and immune deficiency disorders.

View original content to download multimedia:https://www.prnewswire.com/news-releases/penicillin-allergy-awareness--rethinking-and-reevaluating-penicillin-allergy-302886633.html

SOURCE American Academy of Allergy, Asthma & Immunology (AAAAI)